Join us in July as we explore the meaning of privacy, what a federal privacy law in the U.S. might include, cyberthreats in the Internet of Things, medical device cybersecurity in Europe, and more. We hope you can join us.
On October 18, 2018, FDA issued a long-awaited draft revision to its existing guidance “Content of Premarket Submissions for Management of Cybersecurity in Medical Devices”(premarket cybersecurity guidance). This coincided with release of the FDA-supported incident preparedness and response playbook, the announcement of two new Information Sharing Analysis Organizations (ISAOs), and FDA’s recent news release discussing the agency’s enhanced cybersecurity partnership with the U.S. Department of Homeland Security (DHS) earlier this month. FDA’s recent flurry of activity focuses on providing additional clarity about when to interact with FDA, what information would be useful in submissions, and what level of documentation is expected. Cybersecurity clearly is a high priority issue for FDA and the agency is working hard to bring together stakeholders and provide the best information it can so that all entities that are involved in managing the multifaceted and evolving area of cybersecurity have the best and most current information to manage the risks of a cybersecurity intrusion.
Join us this month as our Privacy and Cybersecurity team will discuss medical device cybersecurity preparedness and response, employee monitoring, IoT’s impact on health care, and key legal and compliance issues for insider threat programs.